Abattis Bioceuticals (ATTBF) Northern Vine Labs and the New Canadian Rules -- CFN Media
(firmenpresse) - SEATTLE, WA -- (Marketwired) -- 01/05/17 -- CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article covering Abattis Bioceuticals Corp.''s (OTCQB: ATTBF) (CSE: ATT) Northern Vine Labs subsidiary and the effect newly proposed rules in Canada could have on the business.
The Canadian Cannabis Task Force on Legalization and Regulation recently released its final report on cannabis legalization and regulation. In the report, the task force emphasized the need for mandatory laboratory testing to prevent contaminated products from hitting the market. Licensed producers will also be required to ensure that packaging contains accurate descriptions of a drug''s potency, including tetrahydrocannabinol (THC) and cannabidiol (CBD) levels.
Northern Vine Canada Inc., an Abattis Bioceuticals Corp. subsidiary, is one of only 18 laboratories licensed by Health Canada. With new rules set to take effect in the near-term, the company plans to market its testing services to licensed producers and patients to generate significant revenue in 2017 and beyond. These revenues will be used to help finance the company''s move into functional foods and other areas of the market.
Learn how to become a CFN Media featured company, brand or entrepreneur:
Download the CFN Media iOS mobile app to access the world of cannabis from your smart phone:
Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your iPhone:
CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.
Except for the historical information presented herein, matters discussed in this release contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC, which owns CFN Media and CannabisFN.com, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit: .
CFN Media
Frank Lane
206-369-7050
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 05.01.2017 - 08:00 Uhr
Sprache: Deutsch
News-ID 1478797
Anzahl Zeichen: 2114
contact information:
Contact person:
Town:
SEATTLE, WA
Phone:
Kategorie:
Investment Services & Trading
Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:
Diese Pressemitteilung wurde bisher 218 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Abattis Bioceuticals (ATTBF) Northern Vine Labs and the New Canadian Rules -- CFN Media
"
steht unter der journalistisch-redaktionellen Verantwortung von
CFN Media (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
